ReviewTranslational lung cancer research2023
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease.
Open access · diamondAbstract readReview
In one paragraph
Review in Translational lung cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 24 citations in OpenAlex.
- Effects of Astragalus membranaceus injection at Zusanli (ST36) acupoint on lung cancer with COPD.Medical oncology (Northwood, London, England) · 2026Article
- The Favorable Short-Term Efficacy of Preexisting COPD for Extensive-Stage Small-Cell Lung Cancer Receiving Immunotherapy.Cancer medicine · 2026Article
- Global, regional, and national trends in burden of lung cancer and chronic obstructive pulmonary disease and associated risk factors, 1990-2021: results from the global burden of disease study 2021.NPJ primary care respiratory medicine · 2026Article
- Lung cancer incidence and risk factors in chronic obstructive pulmonary disease: a systematic review and meta-analysis of cohort studies.Journal of thoracic disease · 2026Article
- Trends in cause of death among patients with non-small cell lung cancer in the United States from 2000 to 2021: a SEER-based study.BMC public health · 2026Article
- Preoperative Pulmonary Rehabilitation and Perioperative Outcomes in High-Risk COPD Patients Undergoing Lung Cancer Surgery: A Retrospective Cohort Study.Diagnostics (Basel, Switzerland) · 2026Article
- Article
- Pathogen spectrum of pulmonary infections in kidney transplant recipients and the diagnostic value of mNGS: a sputum and BALF study based on clinical decision-making.Frontiers in cellular and infection microbiology · 2026Article
- A disease potential-driven graph attention model for comorbidity risk prediction of hypertension.Frontiers in big data · 2026Article
- Integrating Machine Learning for Early COPD Prediction in Lung Cancer Patients: A Focus on Systemic Coagulation-Inflammation Index.International journal of chronic obstructive pulmonary disease · 2026Article
- Integrating Disease Burden and Cost-Effectiveness for Value-Based Prioritisation of COPD Interventions: A Narrative Review.International journal of chronic obstructive pulmonary disease · 2026Review
- [Research Progress on the Regulatory Mechanism of Respiratory Microbiota in the Comorbidity of Chronic Obstructive Pulmonary Disease and Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2025Review
- User-centered design of a COPD care pathway for patients with cancer: a mixed-methods clinical trial protocol.Future oncology (London, England) · 2025Article
- The safety and effectiveness of immune checkpoint blockade in lung cancer with COPD: a systematic review and meta-analysis.Journal of thoracic disease · 2025Article
- Comorbidity of lung cancer and chronic obstructive pulmonary disease: correlation and optimization of treatment strategies.Translational lung cancer research · 2025Review
- Whispers in the Lungs: Small Extracellular Vesicles in Lung Cancer and COPD Crosstalk.Cancers · 2025Review
- Exercise rehabilitation on patients with non-small cell lung cancer: A meta-analysis of randomized controlled trials.World journal of clinical cases · 2025Article
- Association of SNPs in nAChRs genes, areca nut chewing and smoking, and their interaction with lung cancer in Hainan, China: a case control study.BMC cancer · 2025Article
- Lung Cancer-Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature).International journal of molecular sciences · 2025Review
- Artemisinin and its derivatives: all-rounders that may prevent the progression from lung injury to lung cancer.Frontiers in pharmacology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
112 authors at 20 institutions in 8 countries.
Chengzhi Zhou *The First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Yinyin Qin *The First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Wei Zhao *Department of Respiratory and Critical Care Medicine, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Zhenyu Liang *The First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Min Li *Department of Respiratory Medicine, Xiangya Cancer Center, Xiangya Hospital, Central South University, Changsha, China.
Dan Liu *Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
Li BaiDepartment of Respiratory Medicine, Xinqiao Hospital Army Medical University, Chongqing, China.
Yahong ChenDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Yan ChenDepartment of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, China.
Yuan ChengDepartment of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China.
Tianqing ChuDepartment of Respiratory Medicine, Shanghai Chest Hospital, Jiaotong University, Shanghai, China.
Qian ChuDepartment of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Haiyi DengThe First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Yuchao DongDepartment of Pulmonary and Critical Care Medicine, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.
Wenfeng FangDepartment of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Xiuhua FuDivision of Respiratory Diseases, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Beili GaoDepartment of Respiratory, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Yiping HanDepartment of Respiratory Medicine, Changhai Hospital, Second Military Medical University, Shanghai, China.
Yong HeDepartment of Pulmonary and Critical Care Medicine, Daping Hospital, Army Medical University, Chongqing, China.
Qunying HongDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Jie HuDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Yi HuDepartment of Medical Oncology, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Liyan JiangDepartment of Respiratory Medicine, Shanghai Chest Hospital, Jiaotong University, Shanghai, China.
Yang JinDepartment of Respiratory and Critical Care Medicine, NHC Key Laboratory of Pulmonary Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Fen LanDepartment of Respiratory Medicine, The Second Affiliated Hospital of Zhejiang University of Medicine, Hangzhou, China.
Qiang LiDepartment of Respiratory Medicine, Shanghai Dongfang Hospital, Shanghai, China.
Shuben LiThe First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Wen LiKey Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Yaqing LiDepartment of Internal Medicine, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
Wenhua LiangThe First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Gen LinDepartment of Thoracic Oncology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, China.
Xinqing LinThe First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Ming LiuThe First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Xiaofang LiuDepartment of Respiratory and Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Xiaoju LiuDepartment of Gerontal Respiratory Medicine, The First Hospital of Lanzhou University, Lanzhou, China.
Zhefeng LiuDepartment of Oncology, General Hospital of Chinese PLA, Beijing, China.
Tangfeng LvDepartment of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Chuanyong MuDepartment of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
Ming OuyangThe First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Jianwen QinDepartment of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Tianjin, China.
Shengxiang RenDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Huanzhong ShiDepartment of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Minhua ShiDepartment of Respiratory Medicine, The Second Affiliated Hospital of Suzhou University, Suzhou, China.
Chunxia SuDepartment of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Jin SuDepartment of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Dejun SunDepartment of Respiratory and Critical Care Medicine, Inner Mongolia Autonomous Region People's Hospital, Hohhot, China.
Yongchang SunDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Huaping TangDepartment of Respiratory Medicine, Qingdao Municipal Hospital, Qingdao, China.
Huijuan WangDepartment of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Kai WangDepartment of Respiratory Medicine, The Second Affiliated Hospital of Zhejiang University of Medicine, Hangzhou, China.
Ke WangDepartment of Respiratory Medicine, The Second Hospital of Jilin University, Changchun, China.
Mengzhao WangDepartment of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Beijing, China.
Qi WangDepartment of Respiratory Medicine, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Wei WangDepartment of Pulmonary and Critical Care Medicine, the First Hospital of China Medical University, Shenyang, China.
Xiaoping WangDepartment of Respiratory Disease, China-Japan Friendship Hospital, Beijing, China.
Yuehong WangDepartment of Respiratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Zhijie WangDepartment of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zirui WangDepartment of Respiratory and Critical Care Medicine, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Lin WuThoracic Medicine Department II, Hunan Cancer Hospital, Changsha, China.
Di WuDepartment of Respiratory Medicine, Shenzhen People's Hospital, Shenzhen, China.
Baosong XieDepartment of Respiratory Medicine, Fujian Provincial Hospital, Fuzhou, China.
Min XieDepartment of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiaohong XieThe First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Zhanhong XieThe First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Shufeng XuDepartment of Respiratory and Critical Care Medicine, First Hospital of Qinhuangdao, Qinhuangdao, China.
Xiaoman XuDepartment of Respiratory Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
Xia YangDepartment of Respiratory Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yan YinDepartment of Pulmonary and Critical Care Medicine, the First Hospital of China Medical University, Shenyang, China.
Zongyang YuDepartment of Pulmonary and Critical Care Medicine, The 900th Hospital of Joint Logistic Support Force, PLA, Fuzhou, China.
Jian ZhangDepartment of Pulmonary and Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Jianqing ZhangSecond Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Jing ZhangDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Xiaoju ZhangDepartment of Respiratory and Critical Care Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.
Yingying ZhangDepartment of Medical Oncology, Xiangya Hospital, Central South University, Changsha, China.
Diansheng ZhongDepartment of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, China.
Qing ZhouGuangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Xiangdong ZhouDepartment of Respiratory Medicine, The First Affiliated Hospital of Army Medical University, Chongqing, China.
Yanbin ZhouDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Bo ZhuChongqing Key Laboratory of Immunotherapy, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Zhengfei ZhuDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Chenxi ZouDepartment of Respiratory and Critical Care Medicine, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Nanshan ZhongThe First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Jianxing HeThe First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Chunxue BaiDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Chengping HuDepartment of Pulmonary Medicine, Xiangya Hospital, Central South University, Changsha, China.
Weimin LiDepartment of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, China.
Yong SongDepartment of Respiratory and Critical Care Medicine, Jinling Hospital, Nanjing, China.
Jianying ZhouDepartment of Respiratory Diseases, The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, China.
Baohui HanDepartment of Pulmonology, Shanghai Chest Hospital, Shanghai, China.
Janos VargaDepartment of Pulmonology, Semmelweis University, Budapest, Hungary.
Esther BarreiroPulmonology Department-Lung Cancer and Muscle Research Group, IMIM-Hospital del Mar, Parc de Salut Mar, Department of Medicine and Life Sciences (MELIS), Pompeu Fabra University (UPF), CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII) Barcelona, Spain.
Hye Yun ParkDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Francesco PetrellaDivision of Thoracic Surgery, IRCCS European Institute of Oncology, Milan, Italy.
Yuichi SaitoDepartment of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
Taichiro GotoLung Cancer and Respiratory Disease Center, Yamanashi Central Hospital, Yamanashi, Japan.
Hitoshi IgaiDepartment of General Thoracic Surgery, Japanese Red Cross Maebashi Hospital, Maebashi, Gunma, Japan.
Sara BravacciniIRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Michele ZanoniIRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Piergiorgio SolliDepartment of Cardio-Thoracic Surgery and Hearth & Lung Transplantation, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Satoshi WatanabeDepartment of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Alfonso FiorelliThoracic Surgery Unit, Universitàdella Campania Luigi Vanvitelli, Naples, Italy.
Takeo NakadaDivision of Thoracic Surgery, Department of Surgery, the Jikei University School of Medicine, Tokyo, Japan.
Yoshinobu IchikiDepartment of General Thoracic Surgery, Saitama Medical University International Medical Center, Saitama, Japan.
Rossana BerardiClinica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.
Nikolaos TsoukalasDepartment of Oncology, 401 General Military Hospital, Athens, Greece.
Nicolas GirardInstitut du Thorax Curie Montsouris, Institut Curie, Paris, France.
Antonio RossiOncology Center of Excellence, Therapeutic Science & Strategy Unit, IQVIA, Milan, Italy.
Antonio PassaroDivision of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy.
Toyoaki HidaLung Cancer Center, Central Japan International Medical Center, Minokamo, Japan.
Shiyue LiThe First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, China.
Liang'an ChenDepartment of Respiratory and Critical Care Medicine, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Rongchang ChenShenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital, Shenzhen, China.
Central South University · CNState Key Laboratory of Respiratory Disease · CNArmy Medical University · CNFirst Affiliated Hospital of Guangzhou Medical University · CNPeking University · CNShanghai Chest Hospital · CNSichuan University · CNChinese People's Liberation Army · CNGuangzhou Medical University · CNPeking University First Hospital · CNPeking University Third Hospital · CNSecond Xiangya Hospital of Central South University · CNXinqiao Hospital · CNXiangya Hospital Central South University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNFudan University · CNSecond Affiliated Hospital of Jilin University · CNSecond Affiliated Hospital of Zhejiang University · CNShenZhen People’s Hospital · CNSun Yat-sen University · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer combined by chronic obstructive pulmonary disease (LC-COPD) is a common comorbidity and their interaction with each other poses significant clinical challenges. However, there is a lack of well-established consensus on the diagnosis and treatment of LC-COPD. Methods: A panel of experts, comprising specialists in oncology, respiratory medicine, radiology, interventional medicine, and thoracic surgery, was convened. The panel was presented with a comprehensive review of the current evidence pertaining to LC-COPD. After thorough discussions, the panel reached a consensus on 17 recommendations with over 70% agreement in voting to enhance the management of LC-COPD and optimize the care of these patients. Results: The 17 statements focused on pathogenic mechanisms (n=2), general strategies (n=4), and clinical application in COPD (n=2) and lung cancer (n=9) were developed and modified. These statements provide guidance on early screening and treatment selection of LC-COPD, the interplay of lung cancer and COPD on treatment, and considerations during treatment. This consensus also emphasizes patient-centered and personalized treatment in the management of LC-COPD. Conclusions: The consensus highlights the need for concurrent treatment for both lung cancer and COPD in LC-COPD patients, while being mindful of the mutual influence of the two conditions on treatment and monitoring for adverse reactions.
Indexed as
chronic obstructive pulmonary disease (COPD)concurrent treatmentLung cancer
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.